Invitation to Annual Meeting of Shareholders


Invitation to Annual Meeting of Shareholders The Board of Directors of Active Biotech AB (publ) has today issued a notification of the Annual General Meeting, which is to take place at 17.00 on 12 April 2000 at the Star Hotel in Lund. The notification is published in today´s editions of Sydsvenskan, Svenska Dagbladet and Post- och Inrikes tidningar. ACTIVE BIOTECH AB (PUBL) THE BOARD OF DIRECTORS Active Biotech AB is a Swedish biotechnology company focused on the research and development of pharmaceuticals and vaccines; our core competence being our knowledge of the human immune system. We have a high quality project portfolio and considerable financial resources. Important products include Dukoral, SBL Cholera vaccine, a vaccine against tourist diarrhoea (ETEC), innovative drugs against MS (SAIK) and cancer (TTS). The turnover of Active Biotech was SEK 267 million in 1999. Active Biotech AB Box 724, S-220 07 Lund, Sweden Tel +46 46-19 20 00 Fax +46 46 19 20 50 E-mail info@activebiotech.com Invitation to Annual Meeting of Shareholders in Active Biotech AB (publ) The shareholders in Active Biotech AB (publ) are hereby invited to attend the Annual General Meeting of Shareholders to be held at 17.00 on Wednesday, 12 april at the Star Hotel in Lund. Following the meeting, the shareholders are invited to Active Biotech's research installation at Scheelevägen 22 in Lund. NOTIFICATION Shareholders, who wish to participate in the Annual General Meeting of Shareholders, must both be entered under their own names (not registered as a trustee) in the register of shareholders maintained by Värdepapperscentralen VPC AB on behalf of the Company, as of 2 april 2000, which means that notification for registration at VPC must be done by Friday, 31 March 2000; and notify the Company of their intention to participate in the Annual General Meeting of Shareholders by no later than 16.00 on Thursday, 6 April 2000. Notification of participation in the Annual General Meeting of Shareholders shall be made in writing to Active Biotech AB (publ), Att. Susanne Jönsson, P. O. Box 724, S-220 07 Lund, by telephone on +46 46 / 19 20 00, by fax on +46 46 / 19 20 50 or via e-mail info@activebiotech.com. Upon notification the following information shall be provided: name, personal identity number/corporate registration number, address and telephone number, together with numbers and type(s) of shares. In order to possess the right to participate in the Annual General Meeting of Shareholders, shareholders whose shares are registered in trust through a bank's trust department or individual stockbroker, must temporarily register the shares with VPC in their own name. Such re-registration must be completed by no later than Friday, 31 March. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/03/15/20000315BIT00610/bit0001.doc http://www.bit.se/bitonline/2000/03/15/20000315BIT00610/bit0002.pdf

About Us

Active Biotech's activity is in the biomedical area. The company focuses on R & D.